Bimat 0.03% Eye Drop
Prescription required
Coupons & Offers
Highlights
composition with strength
Bimatoprost (0.03%w/v)
description
Reduces eye pressure effectively, safe for use during pregnancy, suitable for adults and children, helps prevent optic nerve damage
key benefits
Ocular Hypertension and Glaucoma
side effects
Eye itching
how to use
For external use only. Use it as prescribed by your doctor. Check the label for directions, and gently squeeze the dropper to place the medicine inside the lower eyelid without touching the eye.
pregnancy interaction
Consult Your Doctor
lactation interaction
Safe If Prescribed
driving interaction
Unsafe
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Drogheria Sellers Private Limited
Seller Address
Brigade IRV, 9th & 10th Floors, Nallurhalli, White Field, Bangalore, Banglore, Karnataka, India, 560066 For Support ReachOut : support+drogheria@zeptonow.com
Pharmacy License No.
MH-TZ1-581061, MH-TZ1-581062
Manufacturer or Marketer Name
Ajanta Pharma Limited
Manufacturer or Marketer Address
Ajanta House, Charkop, Kandivli West, Mumbai 400 067, India
Country of Origin
India
Shelf Life
24 months
Expires on or after
October 2026
